Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
crispr therapeutics
detroit blog main
detroit top stories
fda
2
×
gene editing
2
×
indiana blog main
indiana top stories
life sciences
loxo oncology
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
american society of clinical oncology (asco)
amicus therapeutics
anti-inflammatory drugs
What
cancer
2
×
roundup
ahead
allogene
ambien
american
annual
asco
attendees
attention
bio
biotech
camp’s
cash
chicago
city
clinical
combinations
community’s
crispr
days
diversity
drug
expanding
focus
home
hot
immunotherapy
investors
ipo
juno
key
kicks
meeting
million
nearly
new
oncology
oncology’s
potential
Language
Current search:
fda
×
" gene editing "
×
cancer
×
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More